IMMUNE Response

Sustained* immune response and short duration of treatment among patients with asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer1

6 month duration

6 months (26 Weeks)

  • *A sustained immune response was seen out to 26 weeks in the pivotal study (the last time point measured). No conclusions could be made regarding the clinical significance of the observed immune responses1
Short duration of treatment
A Sample PROVENGE Schedule

Approximately 1 month

  • PROVENGE is administered in three 1-hour infusions, each preceded by a standard leukapheresis procedure (a standard cell-collection procedure performed at a blood center)
  • The dosing interval ranged from 1 to 15 weeks in controlled clinical trials
  • Apheresis and PROVENGE infusions will be scheduled 2 to 3 days apart and can start on various days of the week
  • Prior to the first leukapheresis procedure, a venous assessment must be done by the prescribing practitioner